Evidence map›Paper›PMID 37341966›Full record

ReviewJournal of nephrology2023

Archetypal sustained low-efficiency daily diafiltration (SLEDD-f) for critically ill patients requiring kidney replacement therapy: towards an adequate therapy.

Sidharth Sethi, Guneive Mangat, Anvitha Soundararajan, Abhilash Bhat Marakini, Roberto Pecoits-Filho, Raghav Shah, Andrew Davenport, Rupesh Raina

Abstract readReview
PubMed Publisher
In one paragraph

Review in Journal of nephrology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 4 countries.

Sidharth SethiDepartment of Pediatric Nephrology, Kidney Institute, Medanta, The Medicity, Gurgaon, Haryana, India.
Guneive MangatAkron Nephrology Associates/Cleveland Clinic Akron General Medical Center, Akron, OH, USA.
Anvitha SoundararajanAkron Nephrology Associates/Cleveland Clinic Akron General Medical Center, Akron, OH, USA.
Abhilash Bhat MarakiniAkron Nephrology Associates/Cleveland Clinic Akron General Medical Center, Akron, OH, USA.
Roberto Pecoits-FilhoSchool of Medicine, Pontificia Universidade Catolica Do Parana, Curitiba, Brazil.
Raghav ShahAkron Nephrology Associates/Cleveland Clinic Akron General Medical Center, Akron, OH, USA.
Andrew DavenportUCL Centre for Nephrology, Royal Free Hospital, University College London, London, UK.
Rupesh RainaAkron Nephrology Associates/Cleveland Clinic Akron General Medical Center, Akron, OH, USA. rraina@akronchildrens.org.ORCID http://orcid.org/0000-0003-3892-8376
Cleveland Clinic · USAkron Children's Hospital · USMedanta The Medicity · INPontifícia Universidade Católica do Paraná · BRThe Royal Free Hospital · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sustained low-efficiency dialysis is a hybrid form of kidney replacement therapy that has gained increasing popularity as an alternative to continuous forms of kidney replacement therapy in intensive care unit settings. During the COVID-19 pandemic, the shortage of continuous kidney replacement therapy equipment led to increasing usage of sustained low-efficiency dialysis as an alternative treatment for acute kidney injury. Sustained low-efficiency dialysis is an efficient method for treating hemodynamically unstable patients and is quite widely available, making it especially useful in resource-limited settings. In this review, we aim to discuss the various attributes of sustained low-efficiency dialysis and how it is comparable to continuous kidney replacement therapy in efficacy, in terms of solute kinetics and urea clearance, and the various formulae used to compare intermittent and continuous forms of kidney replacement therapy, along with hemodynamic stability. During the COVID-19 pandemic, there was increased clotting of continuous kidney replacement therapy circuits, which led to increased use of sustained low-efficiency dialysis alone or together with extra corporeal membrane oxygenation circuits. Although sustained low-efficiency dialysis can be delivered with continuous kidney replacement therapy machines, most centers use standard hemodialysis machines or batch dialysis systems. Even though antibiotic dosing differs between continuous kidney replacement therapy and sustained low-efficiency dialysis, reports of patient survival and renal recovery are similar for continuous kidney replacement therapy and sustained low-efficiency dialysis. Health care studies indicate that sustained low-efficiency dialysis has emerged as a cost-effective alternative to continuous kidney replacement therapy. Although there is considerable data to support sustained low-efficiency dialysis treatments for critically ill adult patients with acute kidney injury, there are fewer pediatric data, even so, currently available studies support the use of sustained low-efficiency dialysis for pediatric patients, particularly in resource-limited settings.

Indexed as

Acute Kidney InjuryCOVID-19Hybrid Renal Replacement TherapyAdultChildCritical IllnessHumansPandemicsRenal DialysisRenal Replacement TherapyAcute kidney injuryContinuous kidney replacement therapyCritical illnessSLEDSustained low-efficiency dialysis

Identifiers

PMID37341966
OpenAlexW4381470004

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.